Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Parry

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Antisense & Nucleic Acid Drug Development|August 6, 1999
Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouseJ A Sandberg, K S Bouhana, A M Gallegos, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkeyJ A Sandberg, C D Sproul, K S Blanchard, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in miceT J Parry, T A Riccobene, S J Strawn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptorsP A Pavco, K S Bouhana, A M Gallegos, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Antisense & Nucleic Acid Drug Development|August 6, 1999
Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouseJ A Sandberg, K S Bouhana, A M Gallegos, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkeyJ A Sandberg, C D Sproul, K S Blanchard, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in miceT J Parry, T A Riccobene, S J Strawn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptorsP A Pavco, K S Bouhana, A M Gallegos, et al.
Pageof 2